1 - 25 of
272
results
for author:"Hansen T."
in Literature Citations
| An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in males. Koefoed P., Hansen T.V., Woldbye D.P., Werge T., Mors O., Hansen T., Jakobsen K.D., Nordentoft M., Wang A., Bolwig T.G. et al. Acta Psychiatr Scand 120:281-287(2009) · Mapped (1) |
| Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia. Vares M., Saetre P., Deng H., Cai G., Liu X., Hansen T., Rasmussen H.B., Werge T., Melle I., Djurovic S. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 0:0-0(2009) · Mapped (9) |
| Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Rung J., Cauchi S., Albrechtsen A., Shen L., Rocheleau G., Cavalcanti-Proenca C., Bacot F., Balkau B., Belisle A., Borch-Johnsen K. et al. Nat. Genet. 41:1110-1115(2009) · Mapped (33) |
| Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. Kring S.I., Werge T., Holst C., Toubro S., Astrup A., Hansen T., Pedersen O., Sorensen T.I. PLoS ONE 4:e6696-e6696(2009) · Mapped (10) |
| Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Grau K., Hansen T., Holst C., Astrup A., Saris W.H., Arner P., Rossner S., Macdonald I., Polak J., Oppert J.M. et al. Int J Obes (Lond) 0:0-0(2009) · Mapped (4) |
| A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads. Rose C.S., Grarup N., Krarup N.T., Poulsen P., Wegner L., Nielsen T., Banasik K., Faerch K., Andersen G., Albrechtsen A. et al. Diabetologia 52:2122-2129(2009) · Mapped (6) |
| Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. Koutnikova H., Laakso M., Lu L., Combe R., Paananen J., Kuulasmaa T., Kuusisto J., Haring H.U., Hansen T., Pedersen O. et al. PLoS Genet. 5:e1000591-e1000591(2009) · Mapped (6) |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Hum. Mol. Genet. 18:4442-4456(2009) · Mapped (65) |
| Underlying genetic models of inheritance in established type 2 diabetes associations. Salanti G., Southam L., Altshuler D., Ardlie K., Barroso I., Boehnke M., Cornelis M.C., Frayling T.M., Grallert H., Grarup N. et al. Am. J. Epidemiol. 170:537-545(2009) · Mapped (95) |
| Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Grunnet L.G., Nilsson E., Ling C., Hansen T., Pedersen O., Groop L., Vaag A., Poulsen P. Diabetes 58:2402-2408(2009) · Mapped (4) |
| Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine. Sorensen G., Wegener G., Hasselstrom J., Hansen T.V., Wortwein G., Fink-Jensen A., Woldbye D.P. Neuroreport 20:1023-1026(2009) · Mapped (1) |
| Common variants conferring risk of schizophrenia. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B. et al. Nature 460:744-747(2009) · Mapped (9) |
| The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: A multi-centre case-control study and meta-analysis. Saetre P., Lundmark P., Hansen T., Rasmussen H.B., Djurovic S., Melle I., Andreassen O.A., Werge T., Agartz I., Hall H. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 0:0-0(2009) · Mapped (15) |
| CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study. Kobylecki C.J., Jakobsen K.D., Hansen T., Jakobsen I.V., Rasmussen H.B., Werge T. Neuropsychobiology 59:222-226(2009) · Mapped (18) |
| The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. Holmkvist J., Banasik K., Andersen G., Unoki H., Jensen T.S., Pisinger C., Borch-Johnsen K., Sandbaek A., Lauritzen T., Brunak S. et al. PLoS ONE 4:e5872-e5872(2009) · Mapped (6) |
| Tyrosine hydroxylase Val81Met polymorphism: lack of association with schizophrenia. Andreou D., Saetre P., Lundmark P., Hansen T., Timm S., Melle I., Djurovic S., Andreassen O.A., Werge T., Hall H. et al. Psychiatr. Genet. 19:273-274(2009) · Mapped (20) |
| Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits. Rathcke C.N., Holmkvist J., Jorgensen T., Borch-Johnsen K., Hansen T., Pedersen O.B., Vestergaard H. PLoS ONE 4:e5469-e5469(2009) · Mapped (4) |
| MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Huang S., Martin E., Kim S., Yu L., Soudais C., Fremont D.H., Lantz O., Hansen T.H. Proc. Natl. Acad. Sci. U.S.A. 106:8290-8295(2009) · UniProtKB (2) |
| Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy. Kaunisto M.A., Sjolind L., Sallinen R., Pettersson-Fernholm K., Saraheimo M., Frojdo S., Forsblom C., Fagerudd J., Hansen T.K., Flyvbjerg A. et al. Diabetes 58:1710-1714(2009) · Mapped (3) |
| Association study of PDE4B gene variants in scandinavian schizophrenia and bipolar disorder multicenter case-control samples. Kahler A.K., Otn?ss M.K., Wirgenes K.V., Hansen T., Jonsson E.G., Agartz I., Hall H., Werge T., Morken G., Mors O. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 0:0-0(2009) · Mapped (11) |
| Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia. Otnaess M.K., Djurovic S., Rimol L.M., Kulle B., Kahler A.K., Jonsson E.G., Agartz I., Sundet K., Hall H., Timm S. et al. Neurobiol. Dis. 34:518-524(2009) · Mapped (6) |
| Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young. Radha V., Ek J., Anuradha S., Hansen T., Pedersen O., Mohan V. J. Clin. Endocrinol. Metab. 94:1959-1965(2009) · Mapped (4) |
| G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Sparso T., Bonnefond A., Andersson E., Bouatia-Naji N., Holmkvist J., Wegner L., Grarup N., Gjesing A.P., Banasik K., Cavalcanti-Proenca C. et al. Diabetes 58:1450-1456(2009) · Mapped (2) |
| The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Pilgaard K., Jensen C.B., Schou J.H., Lyssenko V., Wegner L., Brons C., Vilsboll T., Hansen T., Madsbad S., Holst J.J. et al. Diabetologia 52:1298-1307(2009) · Mapped (26) |
| Studies of CTNNBL1 and FDFT1 variants and measures of obesity: analyses of quantitative traits and case-control studies in 18,014 Danes. Andreasen C.H., Mogensen M.S., Borch-Johnsen K., Sandbaek A., Lauritzen T., Almind K., Hansen L., Jorgensen T., Pedersen O., Hansen T. BMC Med. Genet. 10:17-17(2009) · Mapped (13) |
